Skip to content
OpenCapital
Get started

Acadia Pharmaceuticals ACAD EBIT

EBIT at other companies

Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$73.23M+15.6%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$44.96M-95.4%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
——
BridgeBio Pharma logo
BridgeBio PharmaBBIO
——
TG Therapeutics logo
TG TherapeuticsTGTX
——
Arrowhead Research logo
Arrowhead ResearchARWR
——

Other financials

Income statement

See full
Revenue$268.1M+9.7%
Gross profit$243.3M+8.6%
Operating income-$4.6M-124%
Net income$3.6M-80.8%
EPS (diluted)$0.02-81.8%

Balance sheet

See full
Cash & equivalents$282.2M+29.6%
Total debt$50.8M-9.3%
Total equity$1.2B+63.1%
Total assets$1.6B+41.8%

Cash flow

See full
Operating cash flow$34.0M+67.2%
CapEx$5.2M—
Free cash flow$28.8M+41.6%

Valuation

See full
Market cap$3.87B+37.0%

Profitability

See full
Gross margin91.5%-0.6pp
Operating margin7.4%-16.2pp
Net margin34.3%+11.3pp
FCF margin18.9%—

Returns & leverage

See full
Return on equity37.3%+0.1pp
Debt / equity0×0.0×
Current ratio3.6×+0.7×

Where this comes from

Calculated from Acadia Pharmaceuticals’s reported figures.

−$4.6Moperating income+$4.0Mincome before tax+$8.1Minterest expense=-$4.62M

The official record: Acadia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Acadia Pharmaceuticals's ebit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Acadia Pharmaceuticals's EBIT?
Acadia Pharmaceuticals (ACAD) reported EBIT of -$4.62M in Q1 2026.
How has Acadia Pharmaceuticals's EBIT changed year-over-year?
Acadia Pharmaceuticals's EBIT decreased by 123.9% year-over-year, from $19.29M to -$4.62M.
What is the long-term trend for Acadia Pharmaceuticals's EBIT?
Over 3 years (2021 to 2025), Acadia Pharmaceuticals's EBIT has grown at a -15.0% compound annual growth rate (CAGR), from -$170.44M to $104.81M.
What does EBIT mean?
Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.